Topical Minoxidil for Hair Regrowth - Quick Reference Sheet

Topical Minoxidil for Hair Regrowth

Created on 09/26/2026 – Quick Reference based on Evidence Review created using AI4L + evidence-mcp / Grok 4 – Audit

Topical minoxidil is a scalp solution or foam used to regrow hair in hereditary pattern hair loss. Trials show more scalp hair than an inactive liquid, though full cosmetic coverage is uncommon. Hormone-lowering oral medications can produce a larger thicker-hair gain in men. Scalp irritation and hair on untreated skin are common; whole-body trade-offs are uncommon but not dismissed. Slow regrowth, when it occurs, lasts only while application continues. (Full Review)

Protocol

Labeled men’s solution
1 mL of 5% solution on the scalp twice daily
Using more, or more often, did not improve results.
Labeled women’s schedules
1 mL of 2% solution twice daily, or 5% foam once daily
Both raised hair counts; a test of whether once-daily foam was not meaningfully worse was missed.
Time of day
Morning and night for twice-daily solution
Night dose 2–4 hours before lying down so the liquid can dry and is less likely to transfer to facial skin.
Time to effect
Possible visible change
2 months
Twice-daily use
Before judging
At least 4 months
Men’s 5% solution
After stopping
Within 3–4 months
Men’s 5% label: regrown hair is lost

Benefits

Contraindications
  • Pregnancy or breast-feeding
  • Age under 18 years
  • Known allergy to minoxidil or to propylene glycol
  • A scalp that is red, inflamed, infected, or painful
Key Interactions
  • Oral minoxidil (combined use)
  • Blood-pressure medications (amlodipine, losartan)
  • Tretinoin on the scalp
  • Over-the-counter scalp products (salicylic acid, hydrocortisone)
  • Supplements with a pressure-lowering effect (high-dose magnesium)

Risk & Side Effects

  • High: Scalp irritation and contact dermatitis; unwanted hypertrichosis
  • Medium: Early increase in shedding
  • Low: Blood pressure and heart-rate effects
  • Speculative: Possible harm in pregnancy and breast-feeding

Monitoring

Marker Target Why
Blood pressure Below 120/80 mmHg Flags rare systemic absorption
Resting heart rate 60–80 beats per minute Rapid heartbeat is a labeled reason to stop
Body weight Stable personal baseline; no population target Sudden gain can mark fluid retention
Hair density in a marked area No established target; track change from the individual’s own baseline Shows whether regrowth is occurring
Pregnancy test, when relevant Negative before starting Label warns of possible fetal harm

Cadence: Clinical checks, not a standing blood panel: blood pressure and heart rate before the first application, at about 4 weeks, at 4 months, then every 6–12 months, sooner if dizziness, chest pain, rapid heartbeat, or swelling appears. Photos at 4 months and 12 months. Weight again if rings or shoes tighten.

Qualitative Assessment

  • Scalp comfort: itch, redness, or scaling in the first month
  • Shed: extra hairs on the comb in the first 2 weeks, then a falloff
  • Coverage: crown fill versus the frontal line, under the same light
  • Facial hair: new hairs at the temples, cheeks, or between the brows
  • Handling: whether the same style covers more scalp than at baseline